Viewing Study NCT02598466


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-01-26 @ 7:31 AM
Study NCT ID: NCT02598466
Status: COMPLETED
Last Update Posted: 2016-02-08
First Post: 2015-11-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module